FOR TRANSLATIONAL RESEARCH IN NUCLEAR MEDICINE.
Arronax Nantes brings together all stakeholders in Nantes working on research and development in nuclear medicine.
This more particularly include the GIP ARRONAX, the laboratories Ceisam, CEMA-Oniris, CRCI2NA, LS2N, Subatech, the CRIP-Oniris core facility and the Nuclear Medicine departments of the University Hospital of Nantes and the ICO.
Arronax Nantes is a stakeholder in the I-SITE NExT, in close collaboration with the LabEx IRON and the SIRIC ILIAD.
our publications
Pourbaix Diagram of Astatine Revisited: Experimental Investigations, Liu L, Maurice R, Galland N, Moisy P, Champion J, Montavon G., Inorg Chem. 29 août 2022;61(34):13462‑70
https://doi.org/10.1021/acs.inorgchem.2c01918Excitation functions of deuteron induced nuclear reactions on dysprosium targets for the production of the theranostic relevant isotopes of terbium, Colucci M, Carminati S, Haddad F, Nigron E, Groppi F, Manenti S., Eur Phys J Plus. 26 oct 2022;137(10):1180. https://doi.org/10.1140/epjp/s13360-022-03378-z
our news
APUI passes 100th patient dose milestone
09/11/22![[Agenda] 15th workshop of the “Tumour Targeting, Imaging, Radiotherapies” network](/wp-content/uploads/2022/10/bandeau-workshop-vir-270x200.jpg)
[Agenda] 15th workshop of the “Tumour Targeting, Imaging, Radiotherapies” network
03/10/22
PRISMAP training course : Translational research of radiopharmaceuticals
19/09/22
Would you tell us about REPARE?
07/09/22
Are you doing your internship at Arronax?
03/08/22
A Lebanese delegation welcomed in Arronax
18/07/22Our equipments
